Chris is the Assistant Professor of the School of Chinese Medicine, HK Baptist University. Chris mainly engaged in integrative clinical services and research of various internal medicine conditions. He is the designer and coordinator of multiple clinical trials and cohorts, which showed that add-on Chinese medicine reduces kidney function decline in diabetes, and was associated with mortality reduction in COVID and acute exacerbated chronic obstructive pulmonary disease. Chris has published over 30 original articles in international peer-reviewed medical journals and has been the investigator of 13 research projects with over HK$25 million funding support.
Chris received clinical Chinese medicine training from the HKBU (BCM&BSc, MCM), Tung Wah Group of Hospitals (clinical training) and Guangzhou University of Chinese Medicine (MD); clinical epidemiology, personalized medicine and internal medicine training from the London School of Hygiene & Tropical Medicine (MSc Public Health), University Medical Center Groningen (overseas training), Queen Mary Hospital and HKU (PhD), receiving 23 awards. Chris has served for Tung Wah Group of Hospitals, Hospital Authority, World Health Organization and KPMG Advisory on clinical medicine, medical research and health policy previously.
Apart from practice and research, Chris also serves as a board member of the World Federation of Chinese Medicine Societies subcommittees (Clinical Effectiveness Assessment Committee, Special Committee on Classics); Co-chair of Clinical practice guideline group, GP-TCM Research Association; and the council/board member and advisor of various government and NGO panels currently.